West Pharmaceutical Services | WST - Operating Profit

Stock Price
237.05
Daily Change
6.10 2.64%
Monthly
-15.05%
Yearly
-29.27%
Q1 Forecast
224.00

West Pharmaceutical Services reported $167.6M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Align Technology USD 184.65M 21.61M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dentsply International USD 512M 401M Sep/2025
Haemonetics USD 58.49M 12.35M Sep/2025
ICU Medical USD 26.86M 52K Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
Quidel USD -704.8M 703M Sep/2025
Repligen USD 12.68M 6.72M Sep/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Terumo JPY 45.1B 10.79B Sep/2025
West Pharmaceutical Services USD 167.6M 13.9M Sep/2025